Medical cannabis: A needs analysis for people with epilepsy
MetadataShow full item record
© 2018 Background and purpose: Medical cannabis may be effective treatment for refractory epilepsy. It is timely to seek users’ and potential users’ opinions in regard to its place in the management of epilepsy. Materials and methods: An online survey was administered to members of an epilepsy support organisation in Western Australia. Experience with cannabis for management of epilepsy was explored, along with desire to trial a particular pharmaceutical formulation(s). Results: People with epilepsy (33/71) and carers (38/71) participated. Fifty-four participants indicated no experience with medical cannabis, although 35, mainly with inadequate response to prescription medicines, were willing to ask for a prescription. Concerns included difficulty accessing cannabis and high cost of this treatment. Tablets/capsules was the most acceptable dosage form for development. Conclusion: These findings suggest wide interest in trialling medical cannabis in individual cases of refractory epilepsy, despite the developing body of literature and some concerns about cost and procurement.
Showing items related by title, author, creator and subject.
Wilkins, C.; Sznitman, S.; Decorte, T.; Hakkarainen, P.; Lenton, Simon (2018)© 2018, Emerald Publishing Limited. Purpose: The purpose of this paper is to explore the characteristics of small-scale cannabis cultivation in New Zealand and Israel. Design/methodology/approach: An online survey of ...
Hakkarainen, P.; Frank, V.; Barratt, Monica; Dahl, H.; Decorte, T.; Karjalainen, K.; Lenton, Simon; Potter, G.; Werse, B. (2015)Background: The production and consumption of cannabis for the treatment of medical conditions is of increasing importance internationally; however, research on different aspects of the phenomenon is still scarce. In this ...
Cannabis, risk and normalisation: Evidence from a Canadian study of socially integrated, adult cannabis usersDuff, Cameron; Erickson, P. (2014)Howard Parker's 'normalisation thesis' has made a significant contribution to youth drug studies in many countries. Parker's thesis has been less investigated, however, for its application across the life course, and few ...